Meda Reviews

7 Reviews
Rating Trends
Recommend to a friend
Approve of CEO
(no image)
Anders Lönner
4 Ratings
  • Helpful (1)


    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Career Opportunities
    Former Employee - Senior Sales Professional in Somerset, NJ
    Former Employee - Senior Sales Professional in Somerset, NJ

    I worked at Meda

    Disapproves of CEO
    Disapproves of CEO


    Meda was a great company to work for because expectations were very clear. I felt that my pay was on the higher end of similar pharma companies. If you had a good manager, communication flowed freely regarding changes. Company car, gas card, Amex all the same as other companies in pharma.


    Management and Senior management were sub-par in my opinion, because they were folks who were not trained in their titles. For example, the person who headed up HR at the time VP of HR didn't have an HR background. Because the company is now a public company things happen to keep share holders happy, regardless of the impact on employees.

    Some people find the use of computers in the field a con, but in the end it was easier than paper. The product message seems to change every 60 days, and docs already know of the products. So, when you have a new spin doctor message, you may end up looking foolish.

    Advice to Management

    Stop making it difficult to hit bonus, stop changing the incentive comp plans, go back to monthly incentive comp, get people in senior positions who actually have practical application in those jobs. I.e. the VP of HR needs to be someone with HR experience and not someone who was in the field 25 years ago, and was promoted in house, and is now running a department they have no business running.

Meda Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Stockholm, Sweden
Size 16 to 50 Employees
Founded Unknown
Type Company - Public (MEDA)
Industry Biotech & Pharmaceuticals
Revenue $1 to $2 billion (USD) per year
Competitors GlaxoSmithKline, Novartis

Think of Meda as a medicine middleman. The specialty pharmaceutical company buys the rights for new medications in their final stages of testing and development and readies them for sale. It works with smaller, research-based companies that don't have manufacturing or marketing operations. Meda's pharmaceuticals treat respiratory, cardiology, pain and inflammation, dermatology and central nervous system illnesses. (Products in these groups generated about 80% of total sales in 2009.) Top sellers include nasal spray Astelin, heart medicine Tambocor, the painkiller Zamadol... More

Work at Meda? Share Your Experiences


Click to Rate